Efficacy and safety of switching from bosentan or ambrisentan to macitentan in pulmonary arterial hypertension: A systematic review and meta-analysis

Overview of attention for article published in Frontiers in Cardiovascular Medicine, December 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 5 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 6,938 followers.

RT @FrontCVMedicine: New Research: Efficacy and safety of switching from bosentan or ambrisentan to macitentan in pulmonary arterial hypert…

08 Dec 2022

Reply Repost Favourite

New Research: Efficacy and safety of switching from bosentan or ambrisentan to macitentan in pulmonary arterial hypertension: A systematic review and meta-analysis: Background There is little evidence of the effectiveness of switching… https://t.co/7rocST

08 Dec 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.